These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 39065626)

  • 1. Combinatorial Delivery of Docetaxel- and Erlotinib-Loaded Functionalized Nanostructured Lipid Carriers for the Treatment of Triple-Negative Breast Cancer Using Quality-by-Design Approach.
    Chaudhuri A; Kumar DN; Srivastava SK; Kumar D; Patil UK; Parmar AS; Singh S; Agrawal AK
    Pharmaceutics; 2024 Jul; 16(7):. PubMed ID: 39065626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionalized solid lipid nanoparticles combining docetaxel and erlotinib synergize the anticancer efficacy against triple-negative breast cancer.
    Chaudhuri A; Naveen Kumar D; Kumar D; Kumar Agrawal A
    Eur J Pharm Biopharm; 2024 Aug; 201():114386. PubMed ID: 38950717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Oral Lipid Based Nano-formulation of Dapagliflozin: Optimization, in vitro Characterization and ex vivo Intestinal Permeation Study.
    Zafar A
    J Oleo Sci; 2020; 69(11):1389-1401. PubMed ID: 33132278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
    Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
    Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan-coated nanostructured lipid carriers for transdermal delivery of tetrahydrocurcumin for breast cancer therapy.
    Truong TH; Alcantara KP; Bulatao BPI; Sorasitthiyanukarn FN; Muangnoi C; Nalinratana N; Vajragupta O; Rojsitthisak P; Rojsitthisak P
    Carbohydr Polym; 2022 Jul; 288():119401. PubMed ID: 35450653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis.
    Pradhan M; Singh D; Murthy SN; Singh MR
    Steroids; 2015 Sep; 101():56-63. PubMed ID: 26049018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables.
    Rathod VR; Shah DA; Dave RH
    Drug Dev Ind Pharm; 2020 Mar; 46(3):443-455. PubMed ID: 32037896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality by design (QbD)-based fabrication of atazanavir-loaded nanostructured lipid carriers for lymph targeting: bioavailability enhancement using chylomicron flow block model and toxicity studies.
    Gurumukhi VC; Bari SB
    Drug Deliv Transl Res; 2022 May; 12(5):1230-1252. PubMed ID: 34110597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication, optimization, and
    Mathur P; Sharma S; Rawal S; Patel B; Patel MM
    J Liposome Res; 2020 Jun; 30(2):182-196. PubMed ID: 31060404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistically Optimized Tacrolimus and Thymoquinone Co-Loaded Nanostructured Lipid Carriers Gel for Improved Topical Treatment of Psoriasis.
    Alam M; Rizwanullah M; Mir SR; Amin S
    Gels; 2023 Jun; 9(7):. PubMed ID: 37504393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted delivery of etoposide to cancer cells by folate-modified nanostructured lipid drug delivery system.
    Zhang S; Lu C; Zhang X; Li J; Jiang H
    Drug Deliv; 2016 Jun; 23(5):1838-45. PubMed ID: 26879035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel-loaded nanostructured lipid carriers functionalized with trastuzumab (Herceptin) for HER2-positive breast cancer cells.
    Varshosaz J; Davoudi MA; Rasoul-Amini S
    J Liposome Res; 2018 Dec; 28(4):285-295. PubMed ID: 28826287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Triamcinolone Acetonide-Loaded Nanostructured Lipid Carriers (NLCs) for Buccal Drug Delivery Using the Box-Behnken Design.
    Kraisit P; Sarisuta N
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29690622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Finasteride-loaded nano-lipidic carriers for follicular drug delivery: preformulation screening and Box-Behnken experimental design for optimization of variables.
    Ramkar S; Suresh PK
    Heliyon; 2022 Aug; 8(8):e10175. PubMed ID: 36042733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-Delivery of erlotinib and resveratrol via nanostructured lipid Carriers: A synergistically promising approach for cell proliferation prevention and ROS-Mediated apoptosis activation.
    Asadollahi L; Mahoutforoush A; Dorreyatim SS; Soltanfam T; Paiva-Santos AC; Peixoto D; Veiga F; Hamishehkar H; Zeinali M; Abbaspour-Ravasjani S
    Int J Pharm; 2022 Aug; 624():122027. PubMed ID: 35850183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evaluation of folate-mediated PEGylated nanostructured lipid carriers for the efficient delivery of furanodiene.
    Zhang J; He Y; Jiang J; Li M; Jin C; Wang L; Wang D
    Drug Dev Ind Pharm; 2017 Oct; 43(10):1610-1618. PubMed ID: 28481661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol loaded functionalized nanostructured lipid carriers for breast cancer targeting: Systematic development, characterization and pharmacokinetic evaluation.
    Poonia N; Kaur Narang J; Lather V; Beg S; Sharma T; Singh B; Pandita D
    Colloids Surf B Biointerfaces; 2019 Sep; 181():756-766. PubMed ID: 31234063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatokinetic assessment of luliconazole-loaded nanostructured lipid carriers (NLCs) for topical delivery: QbD-driven design, optimization, and in vitro and ex vivo evaluations.
    Mahmood A; Rapalli VK; Gorantla S; Waghule T; Singhvi G
    Drug Deliv Transl Res; 2022 May; 12(5):1118-1135. PubMed ID: 33895936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
    Noor NM; Sheikh K; Somavarapu S; Taylor KMG
    Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells.
    Lee SG; Kim CH; Sung SW; Lee ES; Goh MS; Yoon HY; Kang MJ; Lee S; Choi YW
    Int J Nanomedicine; 2018; 13():3263-3278. PubMed ID: 29910614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.